Article Details

Brii Bio acquires Vir's antibody rights for Hepatitis B in Greater China

Retrieved on: 2022-07-04 16:39:40

Tags for this article:

Click the tags to see associated articles and topics

Brii Bio acquires Vir's antibody rights for Hepatitis B in Greater China. View article details on hiswai:

Excerpt

... and marketing rights for Vir's VIR-3434 for Hepatitis B in Greater China. ... Digital Marketing Trends in Inflammatory Bowel Disease ...

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up